Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioventus Inc BVS

Healthcare Medical Instruments & Supplies
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products... see more

Recent & Breaking News (NDAQ:BVS)

ROSEN, A RANKED AND LEADING FIRM, Encourages Bioventus Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BVS

PR Newswire February 2, 2023

Bioventus Shareholder Notice

Newsfile February 1, 2023

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Bioventus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BVS

Newsfile February 1, 2023

BIOVENTUS INC. (NASDAQ: BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bioventus Inc. (NASDAQ: BVS)

PR Newswire February 1, 2023

Bioventus Shareholder Notice

Newsfile January 31, 2023

BIOVENTUS INC. (BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Bioventus Inc. (BVS)

Newsfile January 30, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Bioventus Inc. (BVS) Investors of Class Action and to Actively Participate

Business Wire January 30, 2023

BIOVENTUS INC. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Middle District of North Carolina against Bioventus Inc.

PR Newswire January 30, 2023

Bioventus Deadline Alert

Newsfile January 29, 2023

EQUITY ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Bioventus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BVS

Newsfile January 28, 2023

BIOVENTUS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Bioventus To Contact Him Directly To Discuss Their Options

PR Newswire January 28, 2023

Bioventus Shareholder Notice

Newsfile January 27, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bioventus Inc. of Class Action Lawsuit and Upcoming Deadline - BVS

PR Newswire January 27, 2023

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bioventus Inc. (BVS)

Business Wire January 27, 2023

EQUITY ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Bioventus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BVS

PR Newswire January 26, 2023

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bioventus Inc. (BVS)

Business Wire January 26, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bioventus Inc. of Class Action Lawsuit and Upcoming Deadline - BVS

Newsfile January 25, 2023

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Bioventus Inc. (BVS) Investors

Business Wire January 25, 2023

BIOVENTUS INC. (NASDAQ: BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Bioventus Inc. (NASDAQ: BVS)

PR Newswire January 25, 2023

BIOVENTUS INC. (BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Bioventus Inc. (BVS)

Newsfile January 25, 2023